Life Healthcare stock sits below ZAR 1,301 analyst target

Published on 10/20/2026 at 12:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2025 revenue reached ZAR 25.4 billion, up 6.06 percent year over year. Life Healthcare stock costs EUR 0.67 on October 20, 2026.

Operating figures and valuation

Fiscal year 2025 revenue reached ZAR 25.4 billion on September 30, 2025.
Four analysts set an average 12-month target of ZAR 1,301 on October 16, 2026.
Life Healthcare stock trades at EUR 0.67 at 12:44 p.m. CEST at Lang & Schwarz on October 20, 2026.
The H1 2026 EBITDA margin was 15.8 percent on October 11, 2026.

Life Healthcare, ZAE000145892, Illustration mit AI erstellt.

Life Healthcare (ISIN ZAE000145892) was quoted at EUR 0.67 at Lang & Schwarz on October 20, 2026, at 12:44 p.m. CEST. The key valuation marker is an average 12-month target of ZAR 1,301 from four analysts, while fiscal year 2025 revenue reached ZAR 25,398 million, up 6.06 percent from the prior fiscal year, according to Investing.com.

Target leaves valuation in view

The analyst average gives the stock a concrete valuation reference in its home-market currency. The same Investing.com page shows a target range of ZAR 1,240 to ZAR 1,330 and a 52-week range of ZAc 1,000 to ZAc 1,302. The quotation unit matters: ZAc 1,229 on October 20, 2026 represents ZAR 12.29, while the target is stated in ZAR.

For investors, the comparison is therefore more useful as a valuation signal than as a direct euro-price calculation. Life Healthcare's market capitalization was ZAR 17.6 billion on October 20, 2026, placing the operating scale beside the target range.

Three milestones frame the stock

On September 30, 2025, Life Healthcare reported fiscal-year revenue of ZAR 25,398 million, with the year-over-year increase recorded as 6.06 percent by Investing.com. On October 11, 2026, a Simply Wall St update put first-half 2026 occupancy below 70 percent and the EBITDA margin at 15.8 percent. On October 11, 2026, the same update moved its fair-value estimate from ZAR 12.30 to ZAR 12.40 per share, according to Simply Wall St.

What does the margin mean?

The 15.8 percent first-half EBITDA margin makes cost control and occupancy the clearest operating variables in the current valuation discussion. Simply Wall St also cited ZAR 51 million of cost savings and execution risk in Healthcare Services and renal integration on October 11, 2026. That combination links the target range to operating delivery rather than revenue growth alone.

Euro quote sets the day

The stock's German-market indication was EUR 0.67 at Lang & Schwarz on October 20, 2026, at 12:44 p.m. CEST. The primary listing is on the JSE, where the share was quoted at ZAc 1,229 on October 20, 2026.

The further course of trading is shown by the continuously updated real-time quote of Life Healthcare stock.